Learn How PCF Research Saves Men's Lives
Donate to Fight Prostate Cancer
By the time you read this page, another man will be diagnosed with prostate cancer. It happens every 2 minutes. There’s no better time than now to take action in the fight against prostate cancer.
Donate in honor or in memory of someone special today.
Donate in honor or in memory of someone special today.
Trusted By :
Choose donation amount:
Get the free Prostate Cancer Guide COVID-19 Appendix only
Cutting-Edge Science to Reduce Radiation Side Effects: Q&A with Dr. James Byrne
We are in a race for patients. For your husbands and fathers. For your sons ... and now your daughters.
Precision Oncology, Nursing, and World-Class Care for Veterans
Learn how your donation impacts patients
Stay Bone-Healthy
In addition to all the other rotten tricks advanced prostate cancer plays on a man, here’s a biggie: It messes with your bones. Moreover, androgen deprivation therapy (ADT) and androgen receptor-blocking drugs can also raise your...
Rewriting the Story for Black Men, Part 1:
If you are of African descent, you are at higher risk of getting prostate cancer. However, says PCF-funded physician-scientist Kosj Yamoah, M.D., Ph.D., radiation oncologist and cancer epidemiologist at Moffitt Cancer Center in Tampa, Florida, this...
African DescentCOVID-19, Stress, Vaccines, and Your Immune System
If you’ve felt a higher level of stress over the past year, you’re not alone. One study found that earlier in the pandemic, stress, depression, and anxiety each were present in about 30% of people (for...
Full-On “Kitchen Sink” for High-Risk Localized Prostate Cancer: Intensive Neoadjuvant Hormonal Therapy (part 3)
In several clinical trials, including this one, an intense blast of neoadjuvant androgen deprivation therapy (ADT) and androgen-directed treatment (medications such as abiraterone and enzalutamide) has shown promising results in some men – but not all...
In 1993, PCF created a Competitive Awards program that revolutionized the evaluation and funding of prostate cancer research. Fortune magazine credited PCF with creating the “modern venture philanthropy” model for cancer research—citing the transformative power of PCF’s short grant applications and rapid funding. The awards empowered many young scientists to fill the pipeline...
For Researchers
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has raised more than $800 million in support of cutting-edge research by more than 2,200 research projects at 220 leading cancer centers in 22 countries around the world. Thanks in part to PCF’s commitment to ending death and suffering from prostate cancer, the death rate is down more than 50% and countless more men are alive today as a result. PCF research now impacts more than 70 forms of human cancer by focusing on immunotherapy, the microbiome, and food as medicine.
Learn more about our foundation